Adriaens Consulting BVBA, Aalter, Belgium.
VITO NV (Flemish Institute for Technological Research), Mol, Belgium.
Toxicol In Vitro. 2018 Jun;49:99-115. doi: 10.1016/j.tiv.2017.09.008. Epub 2017 Sep 28.
Assessment of acute eye irritation potential is part of the international regulatory requirements for safety testing of chemicals. In the last decades, many efforts have been made in the search for alternative methods to replace the regulatory in vivo Draize rabbit eye test (OECD TG 405). Success in terms of complete replacement of the regulatory in vivo Draize rabbit eye test has not yet been achieved. The main objective of the CEFIC-LRI-AIMT6-VITO CON4EI (CONsortium for in vitro Eye Irritation testing strategy) project was to develop tiered testing strategies for serious eye damage and eye irritation assessment that can lead to complete replacement of OECD TG 405. A set of 80 reference chemicals (e.g. balanced by important driver of classification and physical state), was tested with seven test methods. Based on the results of this project, three different strategies were suggested. We have provided a standalone (EpiOcular ET-50), a two-tiered and three-tiered strategy, that can be used to distinguish between Cat 1 and Cat 2 chemicals and chemicals that do not require classification (No Cat). The two-tiered and three-tiered strategies use an RhCE test method (EpiOcular EIT or SkinEthic™ EIT) at the bottom (identification No Cat) in combination with the BCOP LLBO (two-tiered strategy) or BCOP OP-KIT and SMI (three-tiered strategy) at the top (identification Cat 1). For our proposed strategies, 71.1% - 82.9% Cat 1, 64.2% - 68.5% Cat 2 and ≥80% No Cat chemicals were correctly identified. Also, similar results were obtained for the Top-Down and Bottom-Up approach.
急性眼刺激潜力评估是化学品安全测试国际监管要求的一部分。在过去的几十年中,人们一直在努力寻找替代方法来替代法规体内 Draize 兔眼测试(OECD TG 405)。 尽管在完全替代法规体内 Draize 兔眼测试方面取得了一定的成功,但尚未实现。CEFIC-LRI-AIMT6-VITO CON4EI(体外眼刺激测试策略联合会)项目的主要目标是开发严重眼损伤和眼刺激评估的分层测试策略,以实现 OECD TG 405 的完全替代。该项目用七种测试方法对 80 种参考化学品(例如通过分类和物理状态的重要驱动因素平衡)进行了测试。基于该项目的结果,提出了三种不同的策略。我们提供了一种独立的(EpiOcular ET-50)、两阶段和三阶段策略,可用于区分 Cat 1 和 Cat 2 化学品以及无需分类的化学品(无 Cat)。两阶段和三阶段策略在底部(识别无 Cat)使用 RhCE 测试方法(EpiOcular EIT 或 SkinEthic™EIT),并与 BCOP LLBO(两阶段策略)或 BCOP OP-KIT 和 SMI(三阶段策略)结合使用顶部(识别 Cat 1)。对于我们提出的策略,71.1%-82.9%的 Cat 1、64.2%-68.5%的 Cat 2 和≥80%的无 Cat 化学品被正确识别。此外,在自上而下和自下而上的方法中也获得了类似的结果。